Publicaciones en colaboración con investigadores/as de Beth Israel Deaconess Medical Center (31)

2024

  1. Impact of Catheter-Drawn Blood Cultures on Patient Management: A Multicenter, Retrospective Cohort Study

    Open Forum Infectious Diseases, Vol. 11, Núm. 7

2022

  1. Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade

    Journal for immunotherapy of cancer, Vol. 10, Núm. 5

  2. Classification, outcomes, and management of misdeployed stents during EUS-guided gastroenterostomy

    Gastrointestinal Endoscopy, Vol. 95, Núm. 1, pp. 80-89

  3. Clinical and technical outcomes of patients undergoing endoscopic ultrasound-guided gastroenterostomy using 20-mm vs15-mm lumen-apposing metal stents

    Endoscopy, Vol. 54, Núm. 7, pp. 680-687

  4. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  5. Erratum: Clinical and technical outcomes of patients undergoing endoscopic ultrasound-guided gastroenterostomy using 20-mm vs15-mm lumen-apposing metal stents (Endoscopy (2021) DOI: 10.1055/a-1654-6914)

    Endoscopy

  6. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies

    Gut, Vol. 71, Núm. 6, pp. 1095-1105

2021

  1. Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial

    Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5020-5027

  2. Younger age in adolescent pregnancies is associated with higher risk of adverse outcomes

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 16

2020

  1. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Nature Medicine, Vol. 26, Núm. 6, pp. 878-885

  2. Congenital Uterine Malformation by Experts (CUME): diagnostic criteria for T-shaped uterus

    Ultrasound in Obstetrics and Gynecology, Vol. 55, Núm. 6, pp. 815-829

2018

  1. Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus?

    Ultrasound in Obstetrics and Gynecology, Vol. 51, Núm. 1, pp. 101-109

  2. The ten commandments of chemoembolization: Expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017

    European Review for Medical and Pharmacological Sciences, Vol. 22, Núm. 2, pp. 372-381

2017

  1. Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody

    Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936

2016

  1. Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma

    Clinical Cancer Research

2013

  1. Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia

    Cancer Cell, Vol. 24, Núm. 5, pp. 575-588

2011

  1. Conclusions and Future Possibilities: IORT

    INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION

  2. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

  3. IORT with Electron-Beam, High-Dose-Rate Brachytherapy or Low-KV/Electronic Brachytherapy: Methodological Comparisons

    INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 99-115

  4. Rationale and Historical Perspective of Intraoperative Irradiation

    INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 3-26